全文获取类型
收费全文 | 16634篇 |
免费 | 878篇 |
国内免费 | 81篇 |
专业分类
耳鼻咽喉 | 113篇 |
儿科学 | 310篇 |
妇产科学 | 145篇 |
基础医学 | 2734篇 |
口腔科学 | 528篇 |
临床医学 | 1349篇 |
内科学 | 3101篇 |
皮肤病学 | 374篇 |
神经病学 | 1908篇 |
特种医学 | 1295篇 |
外科学 | 2335篇 |
综合类 | 84篇 |
一般理论 | 5篇 |
预防医学 | 579篇 |
眼科学 | 339篇 |
药学 | 1215篇 |
中国医学 | 35篇 |
肿瘤学 | 1144篇 |
出版年
2023年 | 52篇 |
2022年 | 95篇 |
2021年 | 207篇 |
2020年 | 171篇 |
2019年 | 222篇 |
2018年 | 276篇 |
2017年 | 230篇 |
2016年 | 302篇 |
2015年 | 396篇 |
2014年 | 540篇 |
2013年 | 655篇 |
2012年 | 969篇 |
2011年 | 1038篇 |
2010年 | 708篇 |
2009年 | 683篇 |
2008年 | 1038篇 |
2007年 | 1138篇 |
2006年 | 1152篇 |
2005年 | 1196篇 |
2004年 | 1106篇 |
2003年 | 1116篇 |
2002年 | 1087篇 |
2001年 | 219篇 |
2000年 | 187篇 |
1999年 | 254篇 |
1998年 | 251篇 |
1997年 | 191篇 |
1996年 | 174篇 |
1995年 | 160篇 |
1994年 | 152篇 |
1993年 | 116篇 |
1992年 | 98篇 |
1991年 | 92篇 |
1990年 | 74篇 |
1989年 | 70篇 |
1988年 | 59篇 |
1987年 | 89篇 |
1986年 | 52篇 |
1985年 | 60篇 |
1984年 | 57篇 |
1983年 | 58篇 |
1982年 | 62篇 |
1981年 | 59篇 |
1980年 | 53篇 |
1979年 | 48篇 |
1978年 | 60篇 |
1977年 | 47篇 |
1976年 | 51篇 |
1974年 | 45篇 |
1973年 | 38篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
81.
Magdolna Hornyak Hans-Peter Hundemer Deborah Quail Dieter Riemann Ulrich Voderholzer Claudia Trenkwalder 《Clinical neurophysiology》2007,118(7):1532-1537
OBJECTIVE: To evaluate the relationship of the severity of restless legs syndrome (RLS) as assessed by a subjective, patient-rated scale (International RLS Study Group Rating Scale, IRLS), and of periodic leg movements in sleep (PLMS) as an objective parameter, in two different patient populations. METHODS: Data of 200 unmedicated patients with idiopathic RLS were evaluated. Group 1 (n=100) consisted of selected patients participating in the Pergolide European Australian RLS (PEARLS) study. Group 2 (n=100) represented an outpatient RLS population investigated in a Sleep Disorders Center. Additionally, Group 1 was also evaluated after a 6 week double-blind treatment period, where 47 patients received pergolide and 53 patients placebo. RESULTS: In unmedicated patients, IRLS scores correlated with the PLMS-arousal index (r=0.22, p=0.033) but not with the PLMS index in Group 1 while no correlation was found in Group 2. The change of the IRLS score under treatment in Group 1 correlated significantly both with the change of the PLMS index (r=0.42, p<0.001) and the change of the PLMS-arousal index (r=0.38, p<0.001). CONCLUSIONS: The IRLS adequately reflects treatment changes of PLMS indices. In unmedicated patients, the IRLS correlates with PLMS indices probably only in selected RLS populations with predefined PSG criteria and high PLM activity. SIGNIFICANCE: The IRLS is an appropriate subjective rating scale for measuring treatment effects in RLS. 相似文献
82.
Eberhard Unsöld Christian Ell Dieter Jocham Ronald Sroka Susanne Stocker 《Lasers in medical science》1990,5(3):309-316
Eight commercially available HPD-photosensitizers intended for photodynamic therapy were tested in a murine tumour model with regard to their therapeutic efficacy. The regrowth delay of the fibrosarcoma SSK-2 on the mouse C3H, Neuherberg-line, was determined 3, 24, 48 and 72 h after injection of the drugs (dose: 9 mg kg–1 body weight). The corresponding pharmacodynamics, as measured by regrowth delay, were approximated by an exponential function and the characterizing coefficients derived. These coefficients served to quantify the photodynamic properties of the drugs.The pharmacodynamics of five substances were compared with those obtained fluorometrically. The latter showed shorter decay constants than the therapy-correlated substances which indicates different metabolic behaviour of the therapeutic and diagnostically useful fluorescent components of haematoporphyrin-derived photosensitizers. 相似文献
83.
Maria Severin Bernd Kirchhof 《Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie》1990,228(1):101-104
Three keratoplasties were carried out on two patients because of nodular degeneration of the cornea. Progress after keratoplasty
could be followed up in one eye for 17 months and in the other two eyes, for 2.5 and 9 years, respectively. The implant with
the short follow-up of only 17 months remained glass-clear; nothing abnormal was discovered during the checkups. In the case
of the other patient in whom a longer follow-up period was possible, the following findings were evident: (1) a remarkably
late epithelial immune response in one eye (after 18 months) with subsequent incomplete reepithelisation and formation of
fine, superficial, cloudy opacity (observation period 2.5 years); (2) formation of dense but flat, superficial areas of opacity
in the cornea of the other eye (observation period 9 years). These areas may be regarded as a precursor of Salzmann’s corneal
degeneration. No difference could be found between the histological findings in the explants and those in a degenerative pannus
or an older scar caused by inflammation of the Bowman membrane. 相似文献
84.
P Bernd 《Brain research》1987,430(1):31-38
It has been shown previously that a subpopulation of long-term (7-14 days) cultured neural crest cells undergoing differentiation possesses receptors for nerve growth factor (NGF). These cells are likely to be targets of NGF during the early stages of embryonic development. This study was conducted to determine whether cells exhibiting neuron-like characteristics (i.e. process formation, presence of putative neurotransmitters) in neural crest cultures have NGF receptors. This was accomplished by combining 125I-NGF radioautography and immunocytochemistry using antibodies against tyrosine hydroxylase, serotonin, and vasoactive intestinal polypeptide. Examination of light microscopic radioautographs revealed that none of the neuron-like cells with tyrosine hydroxylase-like, serotonin-like, or vasoactive intestinal polypeptide-like immunoreactivity bound 125I-NGF, and, therefore, do not possess NGF receptors. It is not known whether the lack of NGF receptors on neuron-like cells is due to the early developmental stage of these cells, or is caused by a difference in the microenvironment in vitro as compared to in vivo. The identity of the cultured neural crest cells which do possess NGF receptors remains to be determined. 相似文献
85.
86.
G. Bruce Pike Gary H. Glover Bob S. Hu Dieter R. Enzmann 《Journal of magnetic resonance imaging : JMRI》1993,3(3):531-539
Cross relaxation between macromolecular protons and water protons is known to be important in biologic tissue. In magnetic resonance (MR) imaging sequences, selective saturation of the characteristically short T2 macromolecular proton pool can produce contrast called magnetization transfer contrast, based on the cross-relaxation process. Selective saturation can be achieved with continuous wave irradiation several kilohertz off resonance or short, intense 0° pulses on resonance. The authors analyze 0° binomial pulses for T2 selective saturation, present design guidelines, and demonstrate the use of these pulses in spin-echo imaging sequences in healthy volunteers and patients. Using the phenomenologic Bloch equations modified for two-site exchange, the authors derive the analytic expressions for water proton relaxation under periodic pulsed saturation of the macromolecular protons. This relaxation is shown to be monoexpo-nential, with a rate constant dependent on the saturation pulse repetition rate and the individual and cross-relaxation rates. 相似文献
87.
Summary A single glass micropipette voltage clamp technique with intracellular dialysis was used to study the effects of the trapidil derivatives AR 12–456 and AR 12–463 on Ca channel currents carried by Bat+ in isolated ventricular cells from mice hearts. Inspite of a more potent inhibition of the cAMP phosphodiesterase from heart (Bartel et al. 1985) a reversible Ca channel blocking action of both compounds could be observed. The concentration of half maximal block was calculated to about 50 mol/l for both derivatives tested. Neither a shift in the current-voltage relationships nor a significant change in the potential for half maximal activation was found. The maximal Ba2+ -conductance was reduced. The steady state inactivation was shifted towards more negative potentials by application of 100 mol/l AR 12–463. The decay of the Ba currents was accelerated in the range of the applied test potentials between –20 and +20 mV. It is concluded that the new trapidil derivatives with more potent inhibitory action on cardiac phosphodiesterase than trapidil can block myocardial Ca channels.
Send offprint requests to B. Nilius 相似文献
88.
Summary -Conotoxin GVIA (-CT) diminished the potassium-induced in vitro release of 3H--aminobutyric acid (3H-GABA) from slices of rat neostriatum in a manner which depended on the concentration of potassium. -CT (0.1 nmol/l) decreased the release of 3H-GABA induced by 25 mmol/l K+ from 11.6% to 6.1% of tissue content, ie. by 48%, while it did not affect the release of 3H-GABA caused by 20 mmol/l K+, which was 4.8% of tissue content. However, in the presence of a polyclonal antiserum or cysteamine (600 mol/l), both of which diminish the effects of endogenous somatostatin, 0.1–10 nmol/l -CT decreased the release of 3H-GABA induced by 20 mmoles/l K+ by 40%. It is concluded that -CT did not only inhibit GABA-neurones, but had an additional inhibitory effect on somatostatin neurones which are known to depress the release of 3H-GABA. It is further concluded that neuronal interactions, which are possible in brain slice preparations, may impede the interpretation of effects of drugs, especially if agents are used which affect basic mechanisms of transmitter release and thus the release of various transmitters from neurones.
Send offprint requests to D. K. Meyer at the above address 相似文献
89.
Spahn Hildegard Wellstein Anton Pflugmann Gabriele Mutschler Ernst Palm Dieter 《Pharmaceutical research》1989,6(2):152-155
Plasma concentrations of metoprolol after acute and repetitive administration of R/S-metoprolol to healthy volunteers were measured by a -adrenoceptor subtype-specific radioreceptor assay (RRA) and by an enantiospecific high-performance liquid chromatographic (HPLC) method. In the RRA, R/S-metoprolol showed a 20-fold 1-subtype selectivity: the S-( – )-enantiomer was 35-fold more potent than the R-( + )-enantiomer. A comparison between S-( – )-metoprolol concentrations detected in the plasma samples by HPLC and those detected by RRA yielded a 1/1 relationship, indicating that active metabolites are not present to a significant extent. These results were independent of the widely scattering metabolic clearance of metoprolol (with the potential of differences in the rate and extent of formation of active metabolites) in the volunteers. In general, HPLC methods can be validated by comparison with RRA in order to clarify whether active metabolites are present and—on the basis of the Ki value from RRA—whether the detection limit of the physicochemical procedure is sufficient to cover the therapeutically relevant range. 相似文献
90.
CGP 6809 — A new nitrosoureido-sugar derivative with activity in human tumor xenografts 总被引:1,自引:0,他引:1
Heinz H. Fiebig Karl H. Widmer Bernd R. Winterhalter Georg W. Löhr 《Cancer chemotherapy and pharmacology》1989,23(6):337-340
Summary CGP 6809 [ethyl-6-deoxy-3,5-di-O-methyl-6-(3-methyl-3-nitrosoureido)--d-glucofuranoside] is a new methylnitrosoureido-sugar derivative that has been shown to be active against a broad spectrum of transplantable tumours in mice and rats [14]. We investigated the anti-tumour effect of CGP 6809 in ten selected, human tumour xenograft lines growing s. c. in nude mice. The p. o. administration of 125 mg/kg per day for 10–15 days was less toxic (lethality 12% in tumour-bearing nude mice) than the i. p. injection of 62.5 mg/kg per day (lethality 22%). The anti-tumour effect was similar for both application routes; two large bowel cancers responded to treatment with CGP 6809, rectal cancer CXF 158 showed a remission, and the rapidly growing, undifferentiated colonic cancer CXF 280 exhibited a transient no-change. Furthermore, remissions were observed in the epidermoid lung cancer LXF 322 and in thyroid cancer 117. Tumour progression was found in another epidermoid lung cancer and in three stomach cancers, one melanoma, and one soft tissure sarcoma. CGP 6809 is a promising new agent for clinical trials, especially for large bowel and epidermoid lung cancer.Supported in part by grant PTB 8467 from the Bundesminister für Forschung und Technologie, Bonn, FRG 相似文献